deferoxamine has been researched along with Ventricular Dysfunction in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Ventricular Dysfunction: A condition in which HEART VENTRICLES exhibit impaired function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vogel, M | 1 |
| Anderson, LJ | 1 |
| Holden, S | 1 |
| Deanfield, JE | 1 |
| Pennell, DJ | 1 |
| Walker, JM | 1 |
| Cazzola, M | 1 |
| Borgna-Pignatti, C | 1 |
| Locatelli, F | 1 |
| Ponchio, L | 1 |
| Beguin, Y | 1 |
| De Stefano, P | 1 |
2 other studies available for deferoxamine and Ventricular Dysfunction
| Article | Year |
|---|---|
Tissue Doppler echocardiography in patients with thalassaemia detects early myocardial dysfunction related to myocardial iron overload.
Topics: Adolescent; Adult; beta-Thalassemia; Cardiomyopathies; Chelating Agents; Deferoxamine; Echocardiogra | 2003 |
A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis.
Topics: Adolescent; beta-Thalassemia; Blood Transfusion; Child; Deferoxamine; Erythropoiesis; Growth; Hemogl | 1997 |